We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Tell Me About It

By CLN Stat
Posted on 14 Dec 2020
Special session talk show highlights novel machine learning algorithm that incorporates serial hs-cTn measurements, other inputs to estimate emergency patients’ risk of myocardial infarction.

A talk show at the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo highlights the experiences of two scientists who applied a machine learning algorithm to predict patients’ likelihood of myocardial infarction (MI). More...
Fred Apple, PhD, DABCC, and Yader Sandoval, MD, FACC, FSCAI, will discuss their findings during this special session at 3 p.m. (U.S. Central Standard Time) on December 13.

This algorithm, designated as the myocardial-ischemia-injury-index (MI3), was developed by Abbott Diagnostics under the patent #US2017/0296085 A1, said Apple, medical director of clinical laboratories, clinical chemistry, clinical and forensic toxicology, and point-of-care testing at Hennepin Healthcare in Minneapolis. Investigators would use this in patients with suspected MI to reflect an individual’s likelihood of having a type 1 MI.

Use of data analytics in laboratory medicine is a key area of AACC’s strategic plan. The 2020 Annual Meeting Organizing Committee (AMOC) “felt it would be of interest to have an interactive talk show format presentation on how algorithms can help providers utilize laboratory testing results and improve patient outcomes,” explained AMOC Chair Paul Jannetto, PhD, DABCC, FAACC. Historically, a time gap has existed between AACC University sessions on Sunday and Annual Scientific Meeting opening plenary.

AMOC added this timely interactive session on machine learning and MI for this unique time slot, he added.

Apple, Sandoval—an interventional cardiologist and senior associate consultant at the Mayo Clinic in Rochester, Minnesota—and others have been studying the MI3 algorithm in suspected type 1 MI, type 2 MI, and nonischemic myocardial injury patients presenting at emergency departments. “It incorporates ‘age, sex, and serial high-sensitivity cardiac troponin (hs-cTn) concentrations’ using gradient boosting to compute a value between 0 and 100 to reflect an individual’s likelihood of MI or no MI,” said Apple.

This allows for an individualized and objective assessment to identify low- and high-risk patients to assist in early patient management, he continued.

At this point, interested labs would have to contact Abbott to request use of the algorithm, and only for research purposes, clarified Apple. As far as he and his colleagues are aware, the U.S. Food and Drug Administration has not cleared it for use in patients, nor has it received the Conformitè Europëenne mark. “Investigators are studying MI3 against established early hs-cTn monitoring to determine its independent benefit compared to current early rule-out/rule-in protocols used globally,” noted Apple.

Physicians, pathologists, PhD scientists, laboratory directors, technologists, and in vitro diagnostic industry scientists are encouraged to attend this session. Participants will “come away with an education regarding a new and exciting concept that may provide a new ‘personalized laboratory medicine’ tool to help manage patients with the goal of improving outcomes,” said Apple.

This special session takes place on December 13 from 3–4 p.m. U.S. Central Standard Time and is worth 1 ACCENT credit.

Related Links:
AACC’s Annual Meeting Talk Show Machine Learning and MI
2020 AACC Annual Scientific Meeting & Clinical Lab Expo

New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Cell and Tissue Culture Plastics
Diamond® SureGro™ Cell and Tissue Culture Plastics
New
C-Reactive Protein Rapid Test
Afinion CRP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: A biomarker discovery pipeline has shown promise as a noninvasive method of diagnosing CRC (Photo courtesy of NCI Center for Cancer Research)

Machine Learning Tool Enables Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States when considering both genders. Colonoscopy remains the gold standard for CRC diagnosis, but it is invasive,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.